Abstract 2037P
Background
Prehabilitation is a process that aims to improve a patient's functional capacity before surgery. It may reduce postoperative complications and improve outcomes in cancer patients, particularly those frail. However, the effectiveness of prehabilitation in frail cancer patients undergoing elective surgery is not well understood. This systematic review and meta-analysis aimed to evaluate prehabilitation's effects on postoperative outcomes in frail cancer patients undergoing elective surgery.
Methods
Our search included electronic databases such as PubMed, Embase, and Cochrane and was conducted until January 2022. We had studies that compared a prehabilitation or preoperative optimization program to standard care, postoperative rehabilitation, or a placebo. The primary outcomes of interest were postoperative complications, length of hospital stay, 30-day mortality, and hospital readmission rate. We used R version 4.0.3 and the metafor and meta packages for statistical analysis.
Results
A total of 8 studies met the inclusion criteria for the meta-analysis, with 581 patients in the prehabilitation group and 675 patients in the control group. The results showed that prehabilitation was associated with a significant reduction in postoperative complications (risk ratio (RR) 0.83, 95% confidence interval (CI) 0.69 to 0.98). Prehabilitation was also associated with a significant reduction in length of hospital stay (mean difference -2.32 days, 95% CI -4.34 to -0.29) and a non-significant reduction in 30-day mortality (RR 0.45, 95% CI 0.13 to 1.59). There was no significant difference in hospital readmission rate between the prehabilitation and control groups (RR 1.09, 95% CI 0.38 to 3.15).
Conclusions
Prehabilitation may improve hospital stay and reduce postoperative complications in frail cancer patients undergoing elective surgery. Further research is needed to confirm these findings and determine rehabilitation interventions' optimal duration and intensity. Clinicians need to consider the potential benefits of prehabilitation in caring for frail cancer patients preparing for surgery.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06